X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2640) 2640
animals (2028) 2028
endocannabinoids (1562) 1562
polyunsaturated alkamides (1239) 1239
humans (1141) 1141
male (1069) 1069
rats (1005) 1005
anandamide (948) 948
arachidonic acids - pharmacology (931) 931
arachidonic acids - metabolism (885) 885
mice (748) 748
polyunsaturated alkamides - pharmacology (746) 746
pharmacology & pharmacy (716) 716
piperidines - pharmacology (599) 599
biochemistry & molecular biology (574) 574
polyunsaturated alkamides - metabolism (556) 556
female (505) 505
neurosciences (485) 485
dose-response relationship, drug (383) 383
rats, wistar (357) 357
lipids (327) 327
brain (325) 325
acid amide hydrolase (320) 320
receptor, cannabinoid, cb1 - metabolism (318) 318
pyrazoles - pharmacology (304) 304
amidohydrolases - metabolism (303) 303
receptors, cannabinoid (301) 301
rats, sprague-dawley (296) 296
cannabinoid receptor (286) 286
cannabinoids (266) 266
endocannabinoid system (266) 266
enzyme inhibitors - pharmacology (265) 265
glycerides - metabolism (260) 260
endocannabinoids - metabolism (259) 259
piperine (255) 255
cells, cultured (253) 253
cell biology (247) 247
benzodioxoles - pharmacology (246) 246
alkaloids - pharmacology (245) 245
activation (241) 241
cannabinoid receptor modulators - metabolism (232) 232
cannabinoids - pharmacology (231) 231
amidohydrolases - antagonists & inhibitors (229) 229
cannabinoid receptors (226) 226
inhibition (224) 224
physiological aspects (214) 214
expression (213) 213
brain - metabolism (210) 210
receptors, drug - metabolism (210) 210
cell line (206) 206
rat-brain (204) 204
fatty acids (201) 201
cannabinoid (199) 199
endocrinology & metabolism (199) 199
analysis (198) 198
cannabinoids - metabolism (197) 197
enzymes (197) 197
cells (196) 196
receptor, cannabinoid, cb1 - antagonists & inhibitors (184) 184
estradiol - analogs & derivatives (181) 181
research (181) 181
endocannabinoid (180) 180
mice, inbred c57bl (180) 180
in vitro techniques (179) 179
estradiol - pharmacology (178) 178
cannabinoid receptor modulators - pharmacology (173) 173
neurons (173) 173
capsaicin - pharmacology (170) 170
receptor (170) 170
rat (169) 169
receptors (168) 168
article (166) 166
disease models, animal (166) 166
hydrolysis (159) 159
polyunsaturated alkamides - chemistry (158) 158
signal transduction (157) 157
metabolism (156) 156
ligands (154) 154
arachidonic acids - chemistry (153) 153
pharmacology (153) 153
endocannabinoids - pharmacology (151) 151
tumor cells, cultured (148) 148
2-arachidonoylglycerol (147) 147
apoptosis (147) 147
chemistry, medicinal (145) 145
molecular characterization (144) 144
receptor, cannabinoid, cb2 - metabolism (143) 143
rodents (142) 142
kinetics (141) 141
cb1 receptor (140) 140
signal transduction - drug effects (140) 140
time factors (139) 139
adult (138) 138
cannabinoid receptor modulators (137) 137
nervous system (135) 135
calcium - metabolism (129) 129
calcium channel blockers - pharmacology (129) 129
cell line, tumor (129) 129
estrogen antagonists - pharmacology (129) 129
brain - drug effects (127) 127
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2669) 2669
Chinese (13) 13
Japanese (8) 8
French (3) 3
Hungarian (2) 2
Russian (2) 2
Czech (1) 1
Hebrew (1) 1
Polish (1) 1
Romanian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Nutrition, ISSN 0007-1145, 07/2014, Volume 112, Issue 2, pp. 203 - 213
Previous research has shown that resveratrol can increase cerebral blood flow (CBF) in the absence of improved cognitive performance in healthy, young human... 
Near-IR spectroscopy | Cognitive performance | Piperine | Cerebral blood flow | Resveratrol | PGC-1-ALPHA | SMALL-INTESTINE | SIRT1 | RAT MODEL | BIOAVAILABILITY | NUTRITION & DIETETICS | GLUCOSE | LIVER | MICE | BRAIN | FMRI | Stilbenes - therapeutic use | Benzodioxoles - blood | Cognition Disorders - blood | Nootropic Agents - metabolism | Humans | Polyunsaturated Alkamides - therapeutic use | Benzodioxoles - metabolism | Cognition Disorders - metabolism | Male | Stilbenes - metabolism | Cognition | Intestinal Absorption | Piperidines - blood | Polyunsaturated Alkamides - blood | Young Adult | Cognition Disorders - prevention & control | Spectroscopy, Near-Infrared | Adult | Female | Alkaloids - metabolism | Benzodioxoles - therapeutic use | Task Performance and Analysis | Nootropic Agents - agonists | Double-Blind Method | Piperidines - metabolism | Stilbenes - agonists | Nootropic Agents - therapeutic use | Cerebrovascular Circulation | Nootropic Agents - blood | Polyunsaturated Alkamides - metabolism | Cross-Over Studies | Pilot Projects | Piperidines - therapeutic use | Alkaloids - blood | Alkaloids - therapeutic use | Stilbenes - blood | Frontal Lobe - blood supply | Dietary Supplements | Cohort Studies | Clinical trials | Nutrition research | Bioavailability | Cognition & reasoning | Metabolites | Dietary supplements | Index Medicus
Journal Article
Molecular Systems Biology, ISSN 1744-4292, 07/2010, Volume 6, Issue 1, pp. 392 - n/a
Obesity is characterised by altered gut microbiota, low‐grade inflammation and increased endocannabinoid (eCB) system tone; however, a clear connection between... 
adipose tissue | lipopolysaccharide (LPS) | endocannabinoids | gut microbiota | obesity | HUMAN ABDOMINAL OBESITY | HIGH-FAT DIET | BIOCHEMISTRY & MOLECULAR BIOLOGY | INDUCED INFLAMMATION | NONALCOHOLIC STEATOHEPATITIS | PREADIPOCYTE DIFFERENTIATION | DIET-INDUCED OBESITY | CANNABINOID TYPE-1 RECEPTOR | INSULIN-RESISTANCE | IMPAIRED ADIPOGENESIS | ADIPOSE-TISSUE | Cannabinoid Receptor Modulators - metabolism | Intestines - drug effects | Adipogenesis - drug effects | Humans | Adipose Tissue - physiopathology | Male | Intestines - metabolism | Bacterial Translocation - drug effects | RNA, Messenger - metabolism | Obesity - microbiology | Adipose Tissue - metabolism | Lipopolysaccharides - blood | Arachidonic Acids - metabolism | Piperidines - pharmacology | Dronabinol - analogs & derivatives | Dronabinol - pharmacology | Endocannabinoids | Disease Models, Animal | Pyrazoles - pharmacology | Caco-2 Cells | Mice, Inbred C57BL | Myeloid Differentiation Factor 88 - genetics | Obesity - physiopathology | Permeability | Glycerides - metabolism | Polyunsaturated Alkamides - metabolism | Obesity - metabolism | Prebiotics | Receptor, Cannabinoid, CB1 - metabolism | Animals | Intestines - microbiology | Myeloid Differentiation Factor 88 - deficiency | Receptor, Cannabinoid, CB1 - genetics | Receptor, Cannabinoid, CB1 - drug effects | Mice | Adipose Tissue - drug effects | Index Medicus | Glycerides | Disease Models | RNA | Mikrobiologi inom det medicinska området | Cannabinoid | Lipopolysaccharides | Polyunsaturated Alkamides | Arachidonic Acids | genetics | Piperidines | pharmacology | Adipose Tissue | Tetrahydrocannabinol | Adipogenesis | Obesity | Intestines | Pyrazoles | microbiology | drug effects | Myeloid Differentiation Factor 88 | Messenger | Bacterial Translocation | blood | Inbred C57BL | physiopathology | CB1 | Microbiology in the medical area | deficiency | Receptor | analogs & derivatives | Animal | metabolism
Journal Article
Journal Article
Nature Neuroscience, ISSN 1097-6256, 10/2010, Volume 13, Issue 10, pp. 1265 - 1270
Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic... 
CANNABINOID RECEPTORS | SYSTEM | NEUROPATHIC PAIN | CB2 RECEPTORS | ACID AMIDE HYDROLASE | INFLAMMATION | IN-VIVO | INJURY | NEUROSCIENCES | RAT MODEL | ANALGESIA | Cannabinoid Receptor Modulators - metabolism | Pyrazoles - therapeutic use | Male | Sciatica - drug therapy | Monoacylglycerol Lipases - metabolism | Arachidonic Acids - metabolism | Cannabinoid Receptor Modulators - therapeutic use | Pain - genetics | Time Factors | Statistics, Nonparametric | Escape Reaction - drug effects | Amidohydrolases - deficiency | Endocannabinoids | Disease Models, Animal | Drug Administration Routes | Rats | Pain - pathology | Rats, Sprague-Dawley | Cannabinoids - pharmacology | Mice, Knockout | Ethylene Glycols - metabolism | Cannabinoids - therapeutic use | Arachidonic Acids - therapeutic use | Hyperalgesia - genetics | Indoles - therapeutic use | Mice | Carrageenan | Enzyme Inhibitors | Spinal Cord - metabolism | Polyunsaturated Alkamides - therapeutic use | Motor Activity - drug effects | Tritium | Pain - chemically induced | Formaldehyde | Pain Threshold - drug effects | Amidohydrolases - metabolism | Oncogene Proteins v-fos - metabolism | Tissue Distribution - drug effects | Drug Administration Schedule | Pain - prevention & control | Gene Expression Regulation - genetics | Mice, Inbred C57BL | Pain Measurement - drug effects | Polyunsaturated Alkamides - metabolism | Feeding Behavior - drug effects | Gene Expression Regulation - drug effects | PPAR alpha - deficiency | Animals | Hyperalgesia - drug therapy | Peripheral Nervous System Diseases | Piperidines - therapeutic use | Cannabinoid Receptor Modulators - antagonists & inhibitors | Chromatography, Liquid - methods | Mass Spectrometry - methods | Cannabinoids | Care and treatment | Pain | Analgesics | Evoked potentials (Electrophysiology) | Physiological aspects | Dosage and administration | Research | Methods | Index Medicus
Journal Article
Journal Article
Obesity, ISSN 1930-7381, 10/2012, Volume 20, Issue 10, pp. 1984 - 1994
Suppressing hyperactive endocannabinoid tone is a critical target for reducing obesity. The backbone of both endocannabinoids 2-arachidonoylglycerol (2-AG) and... 
SYSTEM | ACTIVATION | NUTRITION & DIETETICS | DOCOSAHEXAENOIC ACID | ENDOCANNABINOIDS | LIVER | ENDOCRINOLOGY & METABOLISM | POLYUNSATURATED FATTY-ACIDS | ADIPOCYTE DIFFERENTIATION | RAT-BRAIN | TISSUES | PREADIPOCYTES | Animals, Newborn |